Effects of narcotics and narcotic antagonists on affective disorders, schizophrenia and serum neurohormones.
D000341:Affective Disorders, Psychotic / Q000097:blood* / Q000188:drug therapy; D004311:Double-Blind Method; D004723:Endorphins / Q000378:metabolism*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D008691:Methadone / Q000627:therapeutic use; D009043:Motor Activity / Q000502:physiology; D009270:Naloxone / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D018377:Neurotransmitter Agents / Q000097:blood*; D011388:Prolactin / Q000097:blood; D011897:Random Allocation; D011957:Receptors, Opioid / Q000378:metabolism; D012559:Schizophrenia / Q000097:blood* / Q000188:drug therapy
D004723:Endorphins; D009292:Narcotic Antagonists; D018377:Neurotransmitter Agents; D011957:Receptors, Opioid; D009270:Naloxone; D011388:Prolactin; D008691:Methadone; D006854:Hydrocortisone